Stay updated on ADVM-022 Gene Therapy for Wet AMD Clinical Trial
Sign up to get notified when there's something new on the ADVM-022 Gene Therapy for Wet AMD Clinical Trial page.

Latest updates to the ADVM-022 Gene Therapy for Wet AMD Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated to include new facility and publication information, particularly related to eye diseases and treatments, while removing some previous location and drug information.SummaryDifference10%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11, indicating a revision in the content.SummaryDifference0.1%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference1%
- Check37 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.3%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to ADVM-022 Gene Therapy for Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVM-022 Gene Therapy for Wet AMD Clinical Trial page.